Allergan Will Seek Bimatoprost NDA For Eyelash Growth.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      UNITED States
    • Subject Terms:
      UNITED States. Food & Drug Administration ; ALLERGAN Inc. (1948-2015) 144796497 AGN
    • Subject Terms:
      WHITCUP, Scott
    • Abstract:
      The article reports on the intent of Allergan Inc. to file a New Drug Application with the U.S. Food & Drug Administration (FDA) for its bimatoprost by the end of the third quarter of 2008. The bimatoprost is a synthetic prostaglandin analog as a treatment to stimulate eyelash growth. Executive vice president Scott Whitcup reveals that their exploration of bimatoprost reflects their continuing commitment to provide medical aesthetic treatments with clinically proven safety and efficacy.